Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
.refereed research
 |  |  |  |  | 


Email this article to a friend

Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring

Xi-De Wang email, Karen Reeves email, Feng R Luo email, Li-An Xu email, Francis Lee email, Edwin Clark email and Fei Huang email

Genome Biology 2007, 8:R255doi:10.1186/gb-2007-8-11-r255

Subject areas: Cancer, Drug discovery, Medicine

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.